Newbridge Financial Services Group, Inc. Verve Therapeutics, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $391 Million
- Q1 2025
A detailed history of Newbridge Financial Services Group, Inc. transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 9,340 shares of VERV stock, worth $102,086. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,340
Previous 1,652
465.38%
Holding current value
$102,086
Previous $9,000
366.67%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VERV
# of Institutions
199Shares Held
79.3MCall Options Held
204KPut Options Held
101K-
Alphabet Inc. Mountain View, CA12.3MShares$135 Million5.03% of portfolio
-
Bvf Inc San Francisco, CA6.9MShares$75.5 Million1.39% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$72.4 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$43.7 Million2.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$43.2 Million0.0% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $655M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...